
Nanopass Technologies is a commercial-stage medtech company that focuses on enhancing the targeted delivery of vaccines, therapeutics, and aesthetic treatments. Their core innovation revolves around proprietary MEMS-based micro-needle technology engineered to inject formulations directly into the skin’s dermal layer—a site rich in immune cells—rather than deeper muscular tissue. By providing a virtually pain-free alternative to traditional n...
nanopass.com
Daniel Levitats
Chief Executive Officer
Dr. Yotam Levin
President of Innovation
Dr. Efrat Kochba
VP Medical Affairs